Treatment of metastatic colorectal cancer in a 44‑year‑old woman with internal comorbidities – a case report


MUDr. Věra Benešová

Komplexní onkologické centrum, Nemocnice Jihlava



In this case report, I describe the course of treatment of metastatic colorectal cancer in a 44-year-old woman with type 1 diabetes mellitus with insulin therapy and hypertension. The decision on the treatment sequence respected the current recommendations for the treatment of metastatic colorectal cancer, namely: examination in a multidisciplinary team, determination of the genetic type of the tumor, placement of the tumor and the overall lineage of the patient. Because the tumor was KRAS, NRAS wild-type, multiple liver lesions have been found in both lobes and it was left-sided cancer, systemic chemotherapy FOLFOX6 in combination with an epidermal growth factor receptor inhibitor, panitumumab (Vectibix inj.), has been chosen.


Key words

metastatic colorectal cancer, FOLFOX6 systemic chemotherapy, panitumumab



The full article is only available to subscribers

Become a regular subscriber to our Oncological Review...